等待开盘 10-30 09:30:00 美东时间
0.000
0.00%
Theratechnologies Inc. has received final court approval for its previously announced plan of arrangement involving Future Pak affiliate CB Biotechnology, LLC. Shareholders approved the arrangement at a special meeting on September 12, 2025, and the transaction is expected to close on or around September 25, 2025, pending remaining conditions. Theratechnologies is a biopharmaceutical company focused on innovative therapies, while Future Pak, foun...
09-16 21:10
NEW YORK, Dec. 22, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2023-12-23 01:26
Theseus Pharmaceuticals Inc (NASDAQ: THRX) on Friday, has entered into a definitive merger agreement whereby Concentra Biosciences LLC will acquire Theseus for a price per share of between $3.90 and $4.05 in cash, consisting of a base cash price of $3.90 per share and an addi
2023-12-22 21:58
U.S. stocks traded higher midway through trading, with the Dow Jones gaining around 500 points on Tuesday. The Dow traded up 1.42% to 34,833.89 while the NASDAQ rose 2.34% to 14,089.95. The S&P 500 also rose, gaining, 1.93% to 4,496.87.
2023-11-15 02:11
U.S. stocks traded higher this morning, with the Dow Jones gaining around 400 points on Tuesday. Following the market opening Tuesday, the Dow traded up 1.16% to 34,736.95 while the NASDAQ rose 2.03% to 14,047.59. The S&P 500 also rose, gaining, 1.61% to 4,482.49.
2023-11-14 22:50
THRX: 53% | Theseus Pharmaceuticals Announces Process To Explore Strategic Alternatives BCDA: 166% | Biocardia Announced The FDA Approval Of Its Phase 3 Clinical Trial Of Its CardiAMP Autologous Cell
2023-11-14 21:41
CAMBRIDGE, Mass., Nov. 13, 2023 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on improving the liv...
2023-11-14 05:05
Stifel upgraded Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) to Buy from Hold, with a price target of $20 from $14, after reevaluating the competitive landscape for the 2L GIST market.
2023-08-11 02:09
InvestorsObserver has issued critical PriceWatch Alerts for several stocks, inc...
2023-07-21 23:49